Craft

Advanced
Surrozen

Surrozen

Stock Price

$9.5

2024-10-29

Market Capitalization

$30.5 M

2024-10-29

Revenue

$3.5 M

FY, 2025

Surrozen Summary

Company Summary

Overview
Surrozen is a company that develops tissue injury therapeutics. It focuses on selective activation of the Wnt pathway with targeted antibodies to repair tissues and damaged organs.
Type
Public
Status
Active
Founded
2016
HQ
South San Francisco, CA, US | view all locations
Website
https://www.surrozen.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Craig Parker

    Craig Parker, President, Chief Executive Officer, Director

  • Charles Williams

    Charles Williams, Chief Operating Officer and Chief Financial Officer

  • Yang Li

    Yang Li, Executive Vice President, Research

  • David J. Woodhouse, Chairman

    LocationsView all

    1 location detected

    • South San Francisco, CA HQ

      United States

      171 Oyster Point Blvd #400

    Surrozen Financials

    Summary Financials

    Revenue (Q1, 2026)
    $5.0M
    Net income (Q1, 2026)
    ($127.5M)
    Cash (Q1, 2026)
    $106.9M
    EBIT (Q1, 2026)
    ($10.5M)
    Enterprise value
    ($69.7M)

    Competitors and Similar Companies

    Compare competitors

    Footer menu

    Product

    Solutions

    Resources

    Company

    © Craft.co 2026
    Share price data provided by IEX